Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population‐based study

References

• Tavassoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998; 11: 140–54.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Ductal carcinoma in situ. Cancer Monitoring 2000: 1–8.
   Google Scholar
• Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999; 85: 616–28.
   Google Scholar
• Harris EE, Solin Li. The diagnosis and treatment of ductal carcinoma in situ of the breast. Breast J 2000; 6: 78–95.
   PubMedGoogle Scholar
• Frykberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994; 74 (Suppl 1): 350–61.
   PubMed Web of Science ®Google Scholar
• Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263–71.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 1995; 75: 1310–9.
   Google Scholar
• Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86: 429–38.
   Google Scholar
• Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer 2000; 88: 596–607.
   PubMed Web of Science ®Google Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1992; 16: 1183–96.
   Google Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Christensen Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197–210.
   Google Scholar
• Ringberg A, Idvall I, Ferno M, et al. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur J Surg Oncol 2000; 26: 444–51.
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classifica-tion of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154–7.
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. New Engl J Med 1999; 340: 1455–61.
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Craig PH, Lagios MD, et al. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer 1996; 78: 1138–40.
   Google Scholar
• Solin Li, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 754–63.
   PubMed Web of Science ®Google Scholar
• Solin Li, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int j Radiat Oncol Biol Phys 2001; 50: 991–1002.
   PubMed Web of Science ®Google Scholar
• Giles G, Russell I, Reed R, Marr G, Kavanagh A. In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management. ANZ J Surg 2001; 71: 266–70.
   Google Scholar
• Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadel-phia: Lippincott-Raven, 1998; Chapter 7, Case-control studies.
   Google Scholar
• Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167–80.
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–10.
   Google Scholar
• Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 2003; 39: 622–30.
   PubMed Web of Science ®Google Scholar
• Cheng L, Al-Kaisi NK, Gordon NH, Liu AY, Gebrail F, Shenk RR. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997; 89: 1356–60.
   PubMedGoogle Scholar
• Goldstein NS, Kestin L, Vicini F. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexci-sion in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol 1999; 23: 1340–8.
   Google Scholar
• Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 2001; 9: 1425–7.
   Google Scholar
• Hetelekidis S, Collins L, Silver B, et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer 1999; 85: 427–31.
   PubMed Web of Science ®Google Scholar
• Van Zee KJ, Liberman L, Samli B, et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 1999; 86: 1757–67.
   PubMed Web of Science ®Google Scholar
• Douglas-Jones AG, Logan J, Morgan JM, Johnson R, Williams R. Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast. J Clin Pathol 2002; 55: 581–6.
   Google Scholar
• Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002; 94: 1917–24.
   PubMed Web of Science ®Google Scholar
• Australian Cancer Network. The Pathology Reporting of Breast Cancer. A Guide for Pathologists, Surgeons, Radiologists and Oncologists. North Sydney: IntraMed Educational Group, 2001.
   Google Scholar
• Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammo-graphically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618–24.
   Google Scholar
• Bethwaite P, Smith N, Delahunt B, Kenwright D. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast. J Clin Pathol 1998; 51: 450–4.
   PubMed Web of Science ®Google Scholar
• Douglas-Jones AG, Morgan JM, Appleton MA, et al. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast. J Clin Pathol 2000; 53: 596–602.
   Google Scholar
• Weng EY, Juillard GJ, Parker RG, Chang HR, Gornbein JA. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer 2000; 88: 1643–9.
   Google Scholar
• Leong AS, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol 2001; 115: 709–18.
   Google Scholar
• Hanby AM, Millis RR, Oberman HA. Diagnostic Surgical Pathology. 3rd ed, Vol. 1. Philadelphia: Lippincott Williams & Wilkins, 1999; 335.
   Google Scholar
• Elston CE, Ellis JO, Poller DN. Systemic Pathology. 3rd ed. Vol. 13: The breast. Edinburgh: Churchill Livingstone, 1998; Chapter 14, Ductal carcinoma in situ.
   Google Scholar
• Bijker N, Peterse JL, Duchateau L, et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001; 84: 539–44.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 1997; 80: 1740–5.
   PubMed Web of Science ®Google Scholar
• James LA, Mitchell EL, Menasce L, Varley JM. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 1997; 14: 1059–65.
   PubMed Web of Science ®Google Scholar
• Buerger H, Otterbach F, Simon R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999; 189: 521–6.
   PubMed Web of Science ®Google Scholar
• Aubele M, Mattis A, Zitzelsberger H, et al. Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int J Cancer 2000; 85: 82–6.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Fisher B. Relation of a recurrent intraductal carcinoma (ductal carcinoma in situ) to the primary tumor. J Natl Cancer Inst 2000; 92: 288–9.
   PubMedGoogle Scholar
• Ringberg A, Anagnostaki L, Anderson H, Idvall I, Ferno M. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur J Cancer 2001; 37: 1514–22.
   Google Scholar